Key statistics
As of last trade, Barinthus Biotherapeutics PLC (BRNS:NMQ) traded at 0.631, 12.68% above the 52 week low of 0.56 set on Feb 11, 2026.
52-week range
| Open | 0.695 |
|---|---|
| High | 0.70 |
| Low | 0.5814 |
| Bid | 0.614 |
| Offer | 0.66 |
| Previous close | 0.614 |
| Average volume | 57.70k |
|---|---|
| Shares outstanding | 40.83m |
| Free float | 37.52m |
| P/E (TTM) | -- |
| Market cap | 25.07m USD |
| EPS (TTM) | -1.88 USD |
Data delayed at least 15 minutes, as of Feb 18 2026 18:33 GMT.
More ▼
Announcements
- Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
- Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
- Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
- Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
- Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
More ▼
